Clinical Trials Browser

Active not recruiting × Advanced Malignant Solid Neoplasm × cabozantinib × Clear all

NCT05038839 2025-11-20

Cabozantinib and Pamiparib for the Treatment of Advanced of Refractory Solid Tumors

Phase 1 Active not recruiting

Other solid neoplasm

Advanced Malignant Solid Neoplasm